Current and future approaches in the prevention and treatment of diabetic retinopathy

Louis K Chang1, David Sarraf1,21Jules Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, Los Angeles, CA, USA; 2Department of Ophthalmology, Greater LA VA Healthcare Center, Los Angeles, CAAbstract: Diabetic retinopathy (DR) is a major cause of blindness worldwi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Louis K Chang, David Sarraf
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/77143f98eabb4d7c87b4fbbd1c7da161
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:77143f98eabb4d7c87b4fbbd1c7da161
record_format dspace
spelling oai:doaj.org-article:77143f98eabb4d7c87b4fbbd1c7da1612021-12-02T06:21:39ZCurrent and future approaches in the prevention and treatment of diabetic retinopathy1177-54671177-5483https://doaj.org/article/77143f98eabb4d7c87b4fbbd1c7da1612008-06-01T00:00:00Zhttp://www.dovepress.com/current-and-future-approaches-in-the-prevention-and-treatment-of-diabe-a1797https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Louis K Chang1, David Sarraf1,21Jules Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, Los Angeles, CA, USA; 2Department of Ophthalmology, Greater LA VA Healthcare Center, Los Angeles, CAAbstract: Diabetic retinopathy (DR) is a major cause of blindness worldwide and is the number one cause of blindness in working-age individuals in developed countries. We review the current literature and discuss the pathogenesis, modifying risk factors, genetics, and treatment of DR. Special focus is placed on the rationale and effectiveness of therapeutic modalities, both current and future. Louis K ChangDavid SarrafDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2008, Iss Issue 2, Pp 425-433 (2008)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Louis K Chang
David Sarraf
Current and future approaches in the prevention and treatment of diabetic retinopathy
description Louis K Chang1, David Sarraf1,21Jules Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, Los Angeles, CA, USA; 2Department of Ophthalmology, Greater LA VA Healthcare Center, Los Angeles, CAAbstract: Diabetic retinopathy (DR) is a major cause of blindness worldwide and is the number one cause of blindness in working-age individuals in developed countries. We review the current literature and discuss the pathogenesis, modifying risk factors, genetics, and treatment of DR. Special focus is placed on the rationale and effectiveness of therapeutic modalities, both current and future.
format article
author Louis K Chang
David Sarraf
author_facet Louis K Chang
David Sarraf
author_sort Louis K Chang
title Current and future approaches in the prevention and treatment of diabetic retinopathy
title_short Current and future approaches in the prevention and treatment of diabetic retinopathy
title_full Current and future approaches in the prevention and treatment of diabetic retinopathy
title_fullStr Current and future approaches in the prevention and treatment of diabetic retinopathy
title_full_unstemmed Current and future approaches in the prevention and treatment of diabetic retinopathy
title_sort current and future approaches in the prevention and treatment of diabetic retinopathy
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/77143f98eabb4d7c87b4fbbd1c7da161
work_keys_str_mv AT louiskchang currentandfutureapproachesinthepreventionandtreatmentofdiabeticretinopathy
AT davidsarraf currentandfutureapproachesinthepreventionandtreatmentofdiabeticretinopathy
_version_ 1718399942574211072